Arachidonic acid inhibits cysteinyl-leukotriene receptor activation in human pulmonary vessels.
Walch
Laurence
L
CNRS FRE 2536 Hôpital Broussais, Paris, France.
Norel
Xavier
X
Gascard
Jean-Pierre
JP
Brink
Charles
C
D016718:Arachidonic Acid / Q000494:pharmacology*; D001808:Blood Vessels / Q000187:drug effects* / Q000378:metabolism; D015237:Dinoprost / Q000031:analogs & derivatives*; D004789:Enzyme Activation / Q000187:drug effects*; D028441:F2-Isoprostanes / Q000032:analysis; D006801:Humans; D020024:Leukotriene Antagonists; D008168:Lung / Q000098:blood supply* / Q000187:drug effects; D008565:Membrane Proteins; D011651:Pulmonary Artery / Q000187:drug effects*; D011667:Pulmonary Veins / Q000187:drug effects*; D018077:Receptors, Leukotriene / Q000378:metabolism
D028441:F2-Isoprostanes; D020024:Leukotriene Antagonists; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; C075750:8-epi-prostaglandin F2alpha; D016718:Arachidonic Acid; C412375:cysteinyl leukotriene receptor 2; D015237:Dinoprost; C083169:leukotriene D4 receptor